Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in
Ma VT., Zhou AY., Forati A., et al. JCO PO 2026
Read Publication
Peer-reviewed Publications
Read our peer-reviewed publications and published data across cell-free DNA applications.
-
-
Signatera Peer-Reviewed Publications
View All -
Women's Health Peer-Reviewed Publications
View All -
Organ Health Peer-Reviewed Publications
View All -
Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanoma
Ansstas G., Khaddour K., Sudhaman S., et al. CCR. 2026
Read Publication
-
Sensitivity of Circulating Tumor DNA for Detection of Minimal Residual Disease Recurrence or Relapse in Patients With Melanoma
Steimle AK., Harris MS, Forati A, et al. JCO OA. 2026
Read Publication
-
Circulating Tumor DNA Predicts Response After Definitive Radiation Therapy for Merkel Cell Carcinoma
Murchison, K., Camargo, A., Margalit, D., et al. Adv. Radiat. Oncol. 2026
Read Publication
-
Genomic profiling guided therapy for synchronous SCC and CLL of the parotid gland: a rare case report
Dahiya, R., Weiss, N., Wilson, P., et al. J Surg Case Rep. 2025
Read Publication
-
Personalized Circulating tumor DNA assay to assess long-term clinical benefit in patients with advanced melanoma
Martinez-Villa C, Teixido C, Martin R, et al. Cancers 2025
Read Publication
-
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management
Akaike T, Thakuria M, Silk AW, et al. J Am Acad Dermatol. 2025
Read Publication
-
ctDNA Dynamics Identifies Pseudoprogression in a Metastatic Melanoma Patient Treated With Nivolumab/Relatlimab
Steimle AK, Cho SY, Menon N, et al. Journal of Immunotherapy 2025
Read Publication
-
Circulating Tumor DNA in High‐Risk Stage II/III Cutaneous Melanoma: A Feasibility Study
Rhodin KE, O’Connor MH, Therien A, et al. Ann. Surg. Oncol. 2025
Read Publication
-
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Lo
. Vlachou, B.A. Johnson 3rd, M. Kates et al, Eur Urol Open Sci (2025)
Read Publication
-
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study
Ando K, Hamabe A, Nakamura Y, et al. Ann Surg. 2026
Read Publication
-
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy
Chakrabarti S, et al. Cancers. 2026
Read Publication
-
Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer A Nonrandomized Clinic
Han, H.S. et al; JAMA Oncology 2025
Read Publication
-
Adjuvant endocrine therapy with cyclindependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/ HER2– breast canc
Spring L. M. et al; npj Breast Cancer 2025
Read Publication
-
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasi
Foldi J; JCO Precision Oncology 2025
Read Publication
-
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpas
Mittendorf E. A. et al; Nature Medicine 2025
Read Publication
-
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study
Reason E. H. et al; Ann Surg Oncol 2025
Read Publication
-
Detection and Monitoring of Breast Cancer Local Recurrence Via Circulating Tumor DNA Minimal Residual Disease Assay
Prasath V, et al; JCO Precision Oncology 2025
Read Publication
-
Circulating tumor DNA refines risk stratification of neoadjuvant therapyresistant breast tumors
Magbanua M. J. et al; Nature Communications 2025
Read Publication
-
Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case series
Wong K, et al; Ther Adv Med Oncol 2025
Read Publication
-
Loading More...
